A Clinical Study of Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-025)

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to learn what happens to the amount of enlicitide decanoate in the blood when enlicitide decanoate is given in different formulations.

Key facts

Study ID

NCT06691906

Run by

Merck Sharp & Dohme LLC

People needed

40

Starts

2024-03-18

Expected to finish

2024-05-01

Last updated by the study team

2024-11-18

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Continuous non-smoker who has not used nicotine- and tobacco-containing products for at least 3 months prior to the first dosing.
• Medically healthy with no clinically significant medical history.

You may not qualify if…

• Has a history of gastrointestinal disease or has had a gastric bypass or similar surgery.
• Has a history of cancer (malignancy).

Where it is running

• Celerion (Site 0001) — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.